EPIDEMIOLOGY - Harlan M. Krumholz
Long-Term Trends in the Incidence of and Survival with Heart Failure.
Diastolic Heart Failure in the Community: Clinical Profile, Natural History, Therapy, and Impact of Proposed Diagnostic Criteria.
PATHOPHYSIOLOGY, NEW ASPECTS - James Young
Heart failure: A Review
Autologous Myoblast Infusions
Diastolic Heart Failure
THE PROMISE OF NEW PHARMACOLOGIC THERAPIES: UNFULFILLED Kirkwood Adams
Levosimendan (LIDO) Study.
Omapatrilat (OVERTURE).
TNF alpha inhibitors (ATTACH) Trial.
Endothelin antagonists (RITZ-4).
Eplenerone (EPHESUS)
Candesartan in Heart Failure Trials (CHARM)
Valsartan in MI (VALIANT)
Beta blockers (COMET, CAPRICORN)
DEVICES IN HEART FAILURE: NEW APPROACHES - Mandeep Mehra
ICD-MADIT II
Resynchronization therapy: MIRACLE, COMPANION
Ventricular assist devices, i) Bridge to transplant, ii) Destination therapy
Should we pace the RV? DAVID trial
Cardiac splints (ACORN)
SURGICAL TREATMENTS AND APPROACHES - Patrick McCarthy
CABG The STITCH trial
MVR
Infarct exclusion
Nontransplant surgical alternatives in heart failure.
NOVEL APPROACHES TO HEART FAILURE THERAPY
Exercise in Heart Failure: Is it beneficial? Steven Keteyian,
Sleep disorders l - Mark E. Dunlap
GENETIC MARKERS IN HEART FAILURE
DIASTOLIC DYSFUNCTION - IS IT REALLY HEART FAILURE
